Yesterday it was reported that the Sr. VP & CSO of Enanta Pharmaceuticals (ENTA – Research Report), Yat Sun Or,
Tag: Enanta Pharmaceuticals
RBC Capital Reaffirms Their Hold Rating on Enanta Pharmaceuticals (ENTA)
In a report issued on January 7, Brian Abrahams from RBC Capital maintained a Hold rating on Enanta Pharmaceuticals (ENTA
Enanta Pharmaceuticals (ENTA) Receives a Hold from Oppenheimer
Oppenheimer analyst Jay Olson assigned a Hold rating to Enanta Pharmaceuticals (ENTA – Research Report) today and set a price
Oppenheimer Issues a Hold Rating on Enanta Pharmaceuticals (ENTA)
In a report released today, Jay Olson from Oppenheimer assigned a Hold rating to Enanta Pharmaceuticals (ENTA – Research Report),
RBC Capital Maintains Their Hold Rating on Enanta Pharmaceuticals (ENTA)
In a report released yesterday, Brian Abrahams from RBC Capital maintained a Hold rating on Enanta Pharmaceuticals (ENTA – Research
Enanta Pharmaceuticals (ENTA) Gets a Hold Rating from Oppenheimer
In a report released yesterday, Jay Olson from Oppenheimer assigned a Hold rating to Enanta Pharmaceuticals (ENTA – Research Report),
RBC Capital Remains a Hold on Enanta Pharmaceuticals (ENTA)
RBC Capital analyst Brian Abrahams maintained a Hold rating on Enanta Pharmaceuticals (ENTA – Research Report) today and set a